L3VLUP
ProSign in

PRAX in the 13F filings

Praxis Precision Medicines I · CUSIP 74006W207

Sector · Pharmaceuticals and biotechnologyTheme · Healthcare: biopharma and medtech· L3VLUP-definedTheme · Pharmaceutical preparations
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023
Quarter end
31 Mar 2024
the date the book describes
Filed
24 May 2024
latest of these filings; the earliest 10 May 2024
Managers listing it
7
at least, of 95 tracked, among listed positions
Comparable managers
93
filed both Q4 2023 and Q1 2024; 1 listed it in both
Shares listed
1,768,245
combined, among listed positions
Reported value
$108m
combined, at the quarter end

Among the 93 comparable managers: 5 buyers (opened or added shares) and 2 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.

Managers listing PRAX in Q1 2024

Share of 13F value is the position’s reported value over everything the manager reported that quarter. The share change is against Q4 2023, and only where both filings list the position. A rise in value with no rise in shares is the price, not buying.

7 of 7 holders

ActionFiling
Point72 Asset Management LP954,140$58m0.14%Addedn.a.15 May 2024 (the filing on sec.gov)
Verition Fund Management LLC545,408$33m0.23%Trimmed-157,59214 May 2024 (the filing on sec.gov)
Hudson Bay Capital Management LP93,000$5.7munder 0.1%Newnew15 May 2024 (the filing on sec.gov)
Acadian Asset Management LLC82,254$5.0munder 0.1%Trimmedn.a.10 May 2024 (the filing on sec.gov)
Farallon Capital Management LLC50,000$3.1munder 0.1%Newnew24 May 2024 (the filing on sec.gov)
Woodline Partners LP27,263$1.7munder 0.1%Newnew15 May 2024 (the filing on sec.gov)
Brevan Howard Capital Management LP16,180$987kunder 0.1%Newnew15 May 2024 (the filing on sec.gov)

Largest increases and reductions, by shares

Q4 2023 to Q1 2024, among managers that listed it in both quarters or opened it.

Increases

Reductions

New positions and exits

At least these many: a manager is shown exiting only where its own filing shows the position gone.

New (4)

Exited (0)

No exit shown by a manager’s own filing.

Ownership over time

Every quarter on file. A quarter-end value moves with the price as well as with the shares held; buyers and sellers count comparable managers, by shares.
4 in Q3 2024 to 6 in Q2 2026

Tracked managers listing it, at least.

02468Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
the quarter shown share split complete books; unmarked quarters rest on listed positionsClick a quarter to open it.
PRAX by quarter
QuarterHoldersReported valueBuyersSellers
Q4 20231$16m10
Q1 20247$108m52
Q2 20242$74m22
Q3 20244$179m22
Q4 20244$224m13
Q1 20253$97m21
Q2 20252$147m21
Q3 20253$248m30
Q4 20254$1.4bn186
Q1 20266$2.1bn1512
Q2 20266$2.4bn178

Compare with…

Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.

PRAX and LLY →PRAX and JNJ →PRAX and VRTX →Choose a stock to compare with PRAX →

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.

Which funds own PRAX, latest filings →Back to the 13F Explorer →